HealthDay - System designed to work with magnetic resonance imaging devices
The first heart pacemaker designed to be used safely during certain MRI exams has been approved by the U.S. Food and Drug Administration.
Up to now, patients with pacemakers have been advised not to have an MRI, which has the potential to interfere with a pacemaker's settings and may cause the wiring to overheat, the FDA said in a news release.
The Revo MRI SureScan Pacing System has a built-in function that's meant to be turned on before a person undergoes an MRI. Even with the newly approved device, however, an MRI can only be used on certain people, on certain parts of the body, and under the supervision of specially trained technicians, the agency said.
Of 211 people implanted with the device who had an MRI during clinical testing, none had MRI-related complications, the FDA said.
The Revo device is produced by Medtronic Inc., based in Mounds View, Minn.
Copyright © 2011 HealthDay. All rights reserved.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
MRI Study Suggests Shape of White Matter Hyperintensities May Be Predictive of Cognitive Decline
April 7th 2025Emerging research demonstrated that cognitive declines in memory, executive function and processing speed domains were associated with irregular shape of periventricular/confluent white matter hyperintensities.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.